| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |